Free Cash Flow (Quarterly) Chart

View Free Cash Flow (Quarterly) for ABSI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow (Quarterly) Chart
Start Trial

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -27.56M
March 31, 2026 -26.34M
December 31, 2025 -29.08M
September 30, 2025 -25.99M
June 30, 2025 -17.10M
March 31, 2025 -21.86M
December 31, 2024 -16.99M
September 30, 2024 -20.78M
June 30, 2024 -17.18M
March 31, 2024 -17.86M
December 31, 2023 -14.94M
September 30, 2023 -10.67M
June 30, 2023 -19.49M
Date Value
March 31, 2023 -20.40M
December 31, 2022 -19.13M
September 30, 2022 -23.91M
June 30, 2022 -26.47M
March 31, 2022 -28.01M
December 31, 2021 -25.40M
September 30, 2021 -27.37M
June 30, 2021 -32.23M
March 31, 2021 -13.65M
December 31, 2020 -3.441M
September 30, 2020 -3.443M
June 30, 2020 -3.649M
March 31, 2020 -2.618M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
Twist Bioscience Corp. -8.648M
Prime Medicine, Inc. -41.09M
Beam Therapeutics, Inc. -68.51M
Tenax Therapeutics, Inc. -14.15M
Manhattan Scientifics, Inc. --